A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D
Journal of Clinical Microbiology · 2025
DOI: 10.1128/jcm.01999-24 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Thiciany Blener Lopes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Hepatitis D, Hepatitis Delta Virus, Hepatitis Antibodies, Serologic Tests. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Financiadora de Estudos e Projetos, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Hepatitis D is estimated to affect 12 million people worldwide and is caused by the hepatitis D virus (HDV), a defective virus that requires the presence of the hepatitis B virus (HBV) for infection. Here, we report a new recombinant antigen (DTH10.1) to detect anti-HDV IgG antibodies, designed to include a consensus sequence of the HDV antigen, based on bioinformatic analysis of the eight HDV genotypes. Using serum samples from patients living in the endemic area of the Brazilian Amazon basin, the enzyme-linked immunosorbent assay (ELISA) based on this protein displayed a sensitivity of 90.6% (95% CI: 84.2%–94.5%) and a specificity of 100% (95% CI: 94.2%–100.0%), while a rapid immunochromatographic test (ICT) showed a sensitivity of 91.3% (95% CI: 85.0%–95.1%) and specificity of 99.0% (95% CI: 94.5%–99.95%). Commercial monoclonal antibodies for HBV surface antigen (HBsAg) detection were then added to the test, resulting in a multiplex ICT with a sensitivity of 87.1% (95% CI: 81.3%–91.4%) for HBsAg and 95.2% (95% CI: 90.0%–97.8%) for anti-HDV IgG and specificity of 100% (95% CI: 91.0%–100.0%) and 98.0% (95% CI: 92.9%–99.6%), respectively. Finally, the three tests were evaluated against a panel of 79 patient samples infected, covering the eight HDV genotypes. The results indicated that all the DTH10.1-based tests were able to detect anti-IgG HDV antibodies with high sensitivity and specificity, regardless of the infecting HDV genotype. In conclusion, the prototypes developed for serodiagnosis of HDV using the DTH10.1 recombinant protein are promising tools for the universal diagnosis of HDV infection. IMPORTANCE The manuscript outlines the complete strategy for developing tools for the diagnosis of hepatitis D, including an enzyme-linked immunosorbent assay (ELISA), an immunochromatographic test (ICT), and a multiplex ICT for the simultaneous detection of hepatitis B virus surface antigen and anti-hepatitis D virus (HDV) IgG antibodies. All the tests described are capable of detecting all eight HDV genotypes with high accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Laboratory of Molecular Virology, Fundação Oswaldo Cruz de Rondônia, Porto Velho, State of Rondônia, Brazil.
- French National Reference Center for Hepatitis B, C and D Viruses, Laboratoire de Microbiologie Clinique, Hôpital Avicenne, Bobigny, France.
- Instituto René Rachou, Fundação Oswaldo Cruz-Minas, Belo Horizonte, Brazil.
ORCID-Profile: Thiciany Blener Lopes, Ana Paula Fernandes
Förderung
- Financiadora de Estudos e Projetos
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Instituto Nacional de Ciência e Tecnologia de Vacinas (INCTV)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (Fapemig)
Zitieren
APA
Lopes, T. B., Coelho, F. F., Roca, T. P., Oliveira, J. K. A., Delagarde, V., Brichler, S., Gómez Mendoza, D. P., Villalobos Salcedo, J. M., Vieira, D. S., Le Gal, F., Gazzinelli, R. T., & Fernandes, A. P. (2025). A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01999-24
Vancouver
Lopes TB, Coelho FF, Roca TP, Oliveira JKA, Delagarde V, Brichler S, et al. A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.01999-24
BibTeX
@article{Lopes2025,
author = {Lopes, Thiciany Blener and Coelho, Fabiana Fioravante and Roca, Tárcio Peixoto and Oliveira, Jéssica Karoline Augusta and Delagarde, Valérian and Brichler, Ségolène and Gómez Mendoza, Diana Paola and Villalobos Salcedo, Juan Miguel and Vieira, Deusilene Souza and Le Gal, Frédéric and Gazzinelli, Ricardo Tostes and Fernandes, Ana Paula},
title = {A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D},
journal = {Journal of Clinical Microbiology},
year = {2025},
doi = {10.1128/jcm.01999-24}
}
EUVIMED